Advertisement
Canada markets open in 7 hours 14 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7331
    +0.0008 (+0.11%)
     
  • CRUDE OIL

    84.03
    +0.46 (+0.55%)
     
  • Bitcoin CAD

    87,961.11
    +258.78 (+0.30%)
     
  • CMC Crypto 200

    1,392.81
    -3.73 (-0.27%)
     
  • GOLD FUTURES

    2,352.70
    +10.20 (+0.44%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,770.00
    +202.50 (+1.15%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,926.80
    +298.32 (+0.79%)
     
  • CAD/EUR

    0.6829
    +0.0008 (+0.12%)
     

Analysts Have Drastically Reduced Biogen’s Target Price in March

Analysts Have Drastically Reduced Biogen’s Target Price in March

What Analysts Are Recommending for These Biotech Giants in March(Continued from Prior Part)Analysts’ recommendations and target priceWall Street analysts expect a potential upside of 13.56% for Biogen (BIIB) based on its closing price on March